Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Gait Impairment in Parkinson's Disease
NCT00526630Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Dec 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in Parkinson's disease (PD), sponsored by University of Cincinnati. Started Dec 2007; status: completed.
02
Drugs
methylphenidate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00526630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526630.